SC
EVH icon

Saltoro Capital’s Evolent Health EVH Stock Holding History

Saltoro Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,000
Closed -$495K – 29
2023
Q4 		$495K Buy
+15,000
New +$424K 1.32% 26
2023
Q2 		– Sell
-10,800
Closed -$393K – 61
2023
Q1 		$393K Buy
+10,800
New +$342K 0.24% 37
2022
Q2 		– Sell
-29,214
Closed -$944K – 59
2022
Q1 		$944K Buy
29,214
+11,214
+62% +$294K 0.22% 49
2021
Q4 		$498K Sell
18,000
-13,500
-43% -$387K 0.09% 56
2021
Q3 		$977K Buy
31,500
+8,500
+37% +$204K 0.34% 60
2021
Q2 		$486K Buy
23,000
+7,143
+45% +$143K 0.2% 71
2021
Q1 		$320K Buy
+15,857
New +$302K 0.08% 82

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Saltoro Capital's EVH Position: Q1 2024 in Review

Saltoro Capital sold out of Evolent Health (EVH) in Q1 2024, closing a stake of 15,000 shares — an estimated $495K sold.

Saltoro Capital first reported a position in EVH in Q1 2021 and held it in 7 quarters. The position peaked at $977K in Q3 2021. 251 funds tracked by Wall St. Rank hold EVH as of Q1 2024.

  • Saltoro Capital reported no remaining Evolent Health position as of Q1 2024 after selling out during the quarter.
  • Saltoro Capital sold 15,000 Evolent Health shares in Q1 2024, an estimated $495K.
  • Saltoro Capital first reported a position in Evolent Health in Q1 2021 and held it in 7 quarters.
  • Saltoro Capital's Evolent Health position peaked at $977K in Q3 2021.
  • 251 funds tracked by Wall St. Rank held Evolent Health as of Q1 2024.

Based on Saltoro Capital's 13F filing for Q1 2024, filed 15 May 2024.